|
1
|
Kaatsch P: Epidemiology of childhood
cancer. Cancer Treat Rev. 36:277–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ma X, Huang D, Zhao W, Sun L, Xiong H,
Zhang Y, Jin M, Zhang D, Huang C, Wang H, et al: Clinical
characteristics and prognosis of childhood rhabdomyosarcoma: A
ten-year retro-spective multicenter study. Int J Clin Exp Med.
8:17196–17205. 2015.
|
|
3
|
Hibbitts E, Chi YY, Hawkins DS, Barr FG,
Bradley JA, Dasgupta R, Meyer WH, Rodeberg DA, Rudzinski ER, Spunt
SL, et al: Refinement of risk stratification for childhood
rhabdomyosarcoma using FOXO1 fusion status in addition to
established clinical outcome predictors: A report from the
Children's Oncology Group. Cancer Med. 8:6437–6448. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gui H, Lhospital E, Staddon AP, Nagda SN,
Zager EL, Zhang PJL and Brooks JS: Combined sclerosing and spindle
cell rhabdomyosarcoma in previous craniotomy site: A case report
and a review of the literature. Int J Surg Pathol. 27:328–335.
2019. View Article : Google Scholar
|
|
5
|
Dasgupta R, Fuchs J and Rodeberg D:
Rhabdomyosarcoma. Semin Pediatr Surg. 25:276–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raney RB, Walterhouse DO, Meza JL,
Andrassy RJ, Breneman JC, Crist WM, Maurer HM, Meyer WH, Parham DM
and Anderson JR: Results of the Intergroup Rhabdomyosarcoma Study
Group D9602 protocol, using vincristine and dactinomycin with or
without cyclophosphamide and radiation therapy, for newly diagnosed
patients with low-risk embryonal rhabdomyo-sarcoma: A report from
the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
J Clin Oncol. 29:1312–1318. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Malempati S and Hawkins DS:
Rhabdomyosarcoma: Review of the Children's Oncology Group (COG)
Soft-Tissue Sarcoma Committee experience and rationale for current
COG studies. Pediatr Blood Cancer. 59:5–10. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mascarenhas L, Lyden ER, Breitfeld PP,
Walterhouse DO, Donaldson SS, Rodeberg DA, Parham DM, Anderson JR,
Meyer WH and Hawkins DS: Risk-based treatment for patients with
first relapse or progression of rhabdomyosarcoma: A report from the
Children's Oncology Group. Cancer. 125:2602–2609. 2019.PubMed/NCBI
|
|
9
|
Cliff J, Jorgensen AL, Lord R, Azam F,
Cossar L, Carr DF and Pirmohamed M: The molecular genetics of
chemo-therapy-induced peripheral neuropathy: A systematic review
and meta-analysis. Crit Rev Oncol Hematol. 120:127–140. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Egas-Bejar D and Huh WW: Rhabdomyosarcoma
in adolescent and young adult patients: Current perspectives.
Adolesc Health Med Ther. 5:115–125. 2014.PubMed/NCBI
|
|
11
|
Carvalho LF, Silva AMF and Carvalho AA:
The use of anti-oxidant agents for chemotherapy-induced peripheral
neuropathy treatment in animal models. Clin Exp Pharmacol Physiol.
44:971–979. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Norris L, Karmokar A, Howells L, Steward
WP, Gescher A and Brown K: The role of cancer stem cells in the
anti-carcinogenicity of curcumin. Mol Nutr Food Res. 57:1630–1637.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ellerkamp V, Bortel N, Schmid E, Kirchner
B, Armeanu-Ebinger S and Fuchs J: Photodynamic Therapy Potentiates
the Effects of Curcumin on Pediatric Epithelial Liver Tumor Cells.
Anticancer Res. 36:3363–3372. 2016.PubMed/NCBI
|
|
14
|
Allegra A, Innao V, Russo S, Gerace D,
Alonci A and Musolino C: Anticancer activity of curcumin and its
analogues: preclinical and clinical studies. Cancer Invest.
35:1–22. 2017. View Article : Google Scholar
|
|
15
|
Suskind DL, Wahbeh G, Burpee T, Cohen M,
Christie D and Weber W: Tolerability of curcumin in pediatric
inflam-matory bowel disease: a forced-dose titration study. J
Pediatr Gastroenterol Nutr. 56:277–279. 2013. View Article : Google Scholar :
|
|
16
|
Babu A, Prasanth KG and Balaji B: Effect
of curcumin in mice model of vincristine-induced neuropathy. Pharm
Biol. 53:838–848. 2015. View Article : Google Scholar
|
|
17
|
Greeshma N, Prasanth KG and Balaji B:
Tetrahydrocurcumin exerts protective effect on vincristine induced
neuropathy: Behavioral, biochemical, neurophysiological and
histological evidence. Chem Biol Interact. 238:118–128. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schiborr C, Kocher A, Behnam D, Jandasek
J, Toelstede S and Frank J: The oral bioavailability of curcumin
from micronized powder and liquid micelles is significantly
increased in healthy humans and differs between sexes. Mol Nutr
Food Res. 58:516–527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bortel N, Armeanu-Ebinger S, Schmid E,
Kirchner B, Frank J, Kocher A, Schiborr C, Warmann S, Fuchs J and
Ellerkamp V: Effects of curcumin in pediatric epithelial liver
tumors: Inhibition of tumor growth and alpha-fetoprotein in vitro
and in vivo involving the NFkappaB- and the beta-catenin pathways.
Oncotarget. 6:40680–40691. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei CC, Ball S, Lin L, Liu A, Fuchs JR, Li
PK, Li C and Lin J: Two small molecule compounds, LLL12 and FLLL32,
exhibit potent inhibitory activity on STAT3 in human
rhabdomyo-sarcoma cells. Int J Oncol. 38:279–285. 2011.
|
|
21
|
Harati K, Behr B, Daigeler A, Hirsch T,
Jacobsen F, Renner M, Harati A, Wallner C, Lehnhardt M and
Becerikli M: Curcumin and viscum album extract decrease
proliferation and cell viability of soft-tissue sarcoma cells: an
in vitro analysis of eight cell lines using real-time monitoring
and colorimetric assays. Nutr Cancer. 69:340–351. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hinson AR, Jones R, Crose LE, Belyea BC,
Barr FG and Linardic CM: Human rhabdomyosarcoma cell lines for
rhabdomyosarcoma research: Utility and pitfalls. Front Oncol.
3:1832013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McAllister RM, Melnyk J, Finkelstein JZ,
Adams EC Jr and Gardner MB: Cultivation in vitro of cells derived
from a human rhabdomyosarcoma. Cancer. 24:520–526. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ellerkamp V, Lieber J, Nagel C, Wenz J,
Warmann SW, Fuchs J and Armeanu-Ebinger S: Pharmacological
inhibition of beta-catenin in hepatoblastoma cells. Pediatr Surg
Int. 29:141–149. 2013. View Article : Google Scholar
|
|
25
|
Foucquier J and Guedj M: Analysis of drug
combinations: Current methodological landscape. Pharmacol Res
Perspect. 3:e001492015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Franken NAP, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar
|
|
27
|
Kang MH, Smith MA, Morton CL, Keshelava N,
Houghton PJ and Reynolds CP: National Cancer Institute pediatric
preclinical testing program: Model description for in vitro
cytotoxicity testing. Pediatr Blood Cancer. 56:239–249. 2011.
View Article : Google Scholar
|
|
28
|
Banik U, Parasuraman S, Adhikary AK and
Othman NH: Curcumin: the spicy modulator of breast carcinogenesis.
J Exp Clin Cancer Res. 36:982017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kunnumakkara AB, Bordoloi D, Harsha C,
Banik K, Gupta SC and Aggarwal BB: Curcumin mediates anticancer
effects by modulating multiple cell signaling pathways. Clin Sci
(Lond). 131:1781–1799. 2017. View Article : Google Scholar
|
|
30
|
Panda AK, Chakraborty D, Sarkar I, Khan T
and Sa G: New insights into therapeutic activity and anticancer
properties of curcumin. J Exp Pharmacol. 9:31–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Beevers CS, Li F, Liu L and Huang S:
Curcumin inhibits the mammalian target of rapamycin-mediated
signaling pathways in cancer cells. Int J Cancer. 119:757–764.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Houghton JA, Houghton PJ and Green AA:
Chemotherapy of childhood rhabdomyosarcomas growing as xenografts
in immune-deprived mice. Cancer Res. 42:535–539. 1982.PubMed/NCBI
|
|
33
|
Kang JY, Huang H and Zhu FQ: Effect of
curcumin on growth and function of fibroblast in human hyperplastic
scar. Zhongguo Zhong Xi Yi Jie He Za Zhi. 29:1100–1103. 2009.In
Chinese.
|
|
34
|
Gersey ZC, Rodriguez GA, Barbarite E,
Sanchez A, Walters WM, Ohaeto KC, Komotar RJ and Graham RM:
Curcumin decreases malignant characteristics of glioblastoma stem
cells via induction of reactive oxygen species. BMC Cancer.
17:992017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Seitz G, Warmann SW, Vokuhl CO, Heitmann
H, Treuner C, Leuschner I and Fuchs J: Effects of standard
chemotherapy on tumor growth and regulation of multidrug resistance
genes and proteins in childhood rhabdomyosarcoma. Pediatr Surg Int.
23:431–439. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fruci D, Cho WC, Nobili V, Locatelli F and
Alisi A: Drug trans-porters and multiple drug resistance in
pediatric solid tumors. Curr Drug Metab. 17:308–316. 2016.
View Article : Google Scholar
|
|
37
|
Fulda S: Targeting apoptosis resistance in
rhabdomyosarcoma. Curr Cancer Drug Targets. 8:536–544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dhivya R, Ranjani J, Bowen PK, Rajendhran
J, Mayandi J and Annaraj J: Biocompatible curcumin loaded
PMMA-PEG/ZnO nanocomposite induce apoptosis and cytotoxicity in
human gastric cancer cells. Mater Sci Eng C. 80:59–68. 2017.
View Article : Google Scholar
|
|
39
|
Liu L, Sun L, Wu Q, Guo W, Li L, Chen Y,
Li Y, Gong C, Qian Z and Wei Y: Curcumin loaded polymeric micelles
inhibit breast tumor growth and spontaneous pulmonary metastasis.
Int J Pharm. 443:175–182. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Picone P, Nuzzo D, Caruana L, Messina E,
Scafidi V and Di Carlo M: Curcumin induces apoptosis in human
neuroblastoma cells via inhibition of AKT and Foxo3a nuclear
translocation. Free Radic Res. 48:1397–1408. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shafiee M, Mohamadzade E, ShahidSales S,
Khakpouri S, Maftouh M, Parizadeh SA, Hasanian SM and Avan A:
Current status and perspectives regarding the therapeutic potential
of targeting EGFR pathway by curcumin in lung cancer. Curr Pharm
Des. 23:2002–2008. 2017. View Article : Google Scholar : PubMed/NCBI
|
